Jadwiga Jablonska-Koch
ZMB Member
Jadwiga Jablonska-Koch
Next ZMB-Member
Prof. Dr. Jadwiga Jablonska-Koch
ENT Department
West German Cancer Center (WTZ)
German Cancer Research Center (DKFZ), Partnersite Essen/Düsseldorf
University Hospital Essen
45147 Essen
- +49 201 723 3190
- Website
- Selected Publications
- Publication Metrics
-

- ZMB Research Program
Oncology
Research Overview
We focus on the myeloid cell/ neutrophil-dependent immunoregulatory mechanisms that are responsible for the progression of cancerogenesis and inflammation. We study the molecular mechanisms involved in neutrophil polarization, mobilization and activation, but also complex interaction between regulatory myeloid cells, such as neutrophils, monocytes/macrophages and DCs.
Moreover, we are interested in overall neutrophil biology, i.e. development, differentiation, activation, migration and responses to various inflammatory stimuli in disease. We analyze the role of multiple cytokines (with focus on type I interferons) and growth factors (e.g. G-CSF) in the regulation of emergency myelopoiesis, and neutrophil polarization and homing.
Over the last years we have established and worked on the following main research themes:
- Neutrophil heterogeneity and immunoregulatory activity in disease
- Identification of intracellular factors/signaling pathways contributing to the tumorigenic transformation of neutrophils
- Neutrophil-mediated regulation of angiogenesis
- Type I interferons (IFNs) as immunomodulators
- Exosome-mediated suppression of immune responses in tumor
- The impact of tumor-mediated immunosuppression on the susceptibility to bacterial infections
Selected Publications
-
Harnessing myeloid cells in cancerIn: Molecular Cancer, Vol. 24, 2025, Nr. 1, 69DOI, Online Full Text (Open Access)
-
Hypoxic-ischemic brain injury in neonatal mice sequentially recruits neutrophils with dichotomous phenotype and functionIn: Nature Communications, Vol. 16, 2025, Nr. 1, 9696DOI (Open Access)
-
Neutrophil-specific targeting of STAT3 impairs tumor progression via the expansion of cytotoxic CD8⁺ T cellsIn: Signal Transduction and Targeted Therapy, Vol. 10, 2025, Nr. 1, 279DOI (Open Access)
-
Increased Risk for Infections and Allergic Disease in Hereditary Hemorrhagic TelangiectasiaIn: Journal of Clinical Medicine (JCM), Vol. 13, 2024, Nr. 13, 3752DOI, Online Full Text (Open Access)
-
Neutrophils : Biology and diversityIn: Nephrology Dialysis Transplantation (NDT), Vol. 39, 2024, Nr. 10, pp. 1551 – 1564DOI (Open Access)
-
Comparative transcriptomic and proteomic signature of lung alveolar macrophages reveals the integrin CD11b as a regulatory hub during pneumococcal pneumonia infectionIn: Frontiers in Immunology, Vol. 14, 2023, 1227191DOI, Online Full Text (Open Access)
-
Exosomes in Cancer Progression and Therapy Resistance : Molecular Insights and Therapeutic OpportunitiesIn: Life, Vol. 13, 2023, Nr. 10, 2033DOI (Open Access)
-
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaIn: Journal for ImmunoTherapy of Cancer, Vol. 11, 2023, Nr. 4, e004150DOI (Open Access)
-
Nonfunctional TGF-β/ALK1/ENG signaling pathway supports neutrophil proangiogenic activity in hereditary hemorrhagic telangiectasiaIn: Journal of Leukocyte Biology (JLB), Vol. 114, 2023, Nr. 6, pp. 639 – 650DOI (Open Access)
-
Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patientsIn: Molecular Medicine, Vol. 29, 2023, Nr. 1, 69DOI (Open Access)
-
Sellhi neutrophils : A key to triumph in cancer therapyIn: Signal Transduction and Targeted Therapy, Vol. 8, 2023, Nr. 1, 421DOI, Online Full Text (Open Access)
-
Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasiaIn: Scientific Reports, Vol. 12, 2022, Nr. 1, 5877DOI, Online Full Text (Open Access)
-
During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodesIn: Cell Reports, Vol. 40, 2022, Nr. 7, 111171DOI (Open Access)
-
Efficient Small Extracellular Vesicles (EV) Isolation Method and Evaluation of EV-Associated DNA Role in Cell–Cell Communication in CancerIn: Cancers, Vol. 14, 2022, Nr. 9, 2068DOI (Open Access)
-
Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck CancerIn: Cells, Vol. 11, 2022, Nr. 5, 902DOI, Online Full Text (Open Access)
-
IFNAR1 Deficiency Impairs Immunostimulatory Properties of Neutrophils in Tumor-Draining Lymph NodesIn: Frontiers in Immunology, Vol. 13, 2022DOI (Open Access)
-
PMN‐MDSC in newborns : Regulation of the regulatorsIn: Journal of Leukocyte Biology (JLB), Vol. 112, 2022, Nr. 5, pp. 949 – 950DOI (Open Access)
-
SIRT1‐mediated deacetylation of FOXO3a transcription factor supports pro‐angiogenic activity of interferon‐deficient tumor‐associated neutrophilsIn: International Journal of Cancer, Vol. 150, 2022, Nr. 7, pp. 1198 – 1211DOI (Open Access)
-
TLR2-induced CD8⁺ T-cell deactivation shapes dendritic cell differentiation in the bone marrow during sepsisIn: Frontiers in Immunology, Vol. 13, 2022, 945409DOI (Open Access)
-
The Good, the Bad, and the Ugly : Neutrophils, Angiogenesis, and CancerIn: Cancers, Vol. 14, 2022, Nr. 3, 536DOI, Online Full Text (Open Access)
-
B-helper neutrophils in regional lymph nodes correlate with improved prognosis in patients with head and neck cancerIn: Cancers, Vol. 13, 2021, Nr. 12, 3092DOI, Online Full Text (Open Access)
-
Neutrophil dynamics, plasticity and function in acute neurodegeneration following neonatal hypoxia-ischemiaIn: Brain, Behavior and Immunity, Vol. 92, 2021, pp. 234 – 244DOI (Open Access)
-
Das Mikrobiom bei Kopf-Hals-Tumoren – erste Erkenntnisse und AusblickIn: HNO, Vol. 68, 2020, Nr. 12, pp. 905 – 910
-
Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic TelangiectasiaIn: Journal of Clinical Medicine (JCM), Vol. 9, 2020, Nr. 3, 767DOI, Online Full Text (Open Access)
-
Oral Neutrophils : Underestimated Players in Oral CancerIn: Frontiers in Immunology, Vol. 11, 2020, pp. 565683DOI, Online Full Text (Open Access)
-
Challenges in the Isolation and Proteomic Analysis of Cancer Exosomes : Implications for Translational ResearchIn: Proteomes, Vol. 7, 2019, Nr. 2, 22DOI, Online Full Text (Open Access)
-
Detrimental Effect of Type I IFNs During Acute Lung Infection With Pseudomonas aeruginosa Is Mediated Through the Stimulation of Neutrophil NETosis.In: Frontiers in Immunology, Vol. 10, 2019, pp. 2190DOI, Online Full Text (Open Access)
-
Interactions among myeloid regulatory cells in cancerIn: Cancer Immunology, Immunotherapy, Vol. 68, 2019, Nr. 4, pp. 645 – 660DOI, Online Full Text (Open Access)
-
NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophilsIn: International Journal of Cancer, Vol. 144, 2019, Nr. 1, pp. 136 – 149
-
Neutrophil maturation and survival is controlled by IFN-dependent regulation of NAMPT signalingIn: International Journal of Molecular Sciences (IJMS), Vol. 20, 2019, Nr. 22, pp. 5584DOI, Online Full Text (Open Access)
-
Prognostic Role of Blood NETosis in the Progression of Head and Neck CancerIn: Cells, Vol. 8, 2019, Nr. 9, pp. 946DOI, Online Full Text (Open Access)
-
Transfer of manipulated tumor-associated neutrophils into tumor-bearing mice to study their angiogenic potential in vivoIn: JoVE, Vol. 2019, 2019, Nr. 149, pp. e59807
-
Drosophila Hsp67Bc hot-spot variants alter muscle structure and functionIn: Cellular and Molecular Life Sciences - CMLS, Vol. 75, 2018, Nr. 23, pp. 4341 – 4356DOI (Open Access)
-
Neutrophil, quo vadis?In: Journal of Leukocyte Biology (JLB), Vol. 102, 2017, Nr. 3, pp. 685 – 688
-
The regulation of pre-metastatic niche formation by neutrophilsIn: OncoTarget, Vol. 8, 2017, Nr. 67, pp. 112132 – 112144DOI (Open Access)
-
The regulatory effect of Type I IFNs on neutrophil angiogenic capability in tumor microenvironmentIn: European Journal of Immunology, Vol. 47, 2017, Nr. S2, Special Issue: 47th Annual Meeting of the German Society for Immunology, 12–15 September, 2017, Erlangen, Germany, pp. 306
-
Growing tumors induce a local STING dependent Type I IFN response in dendritic cellsIn: International Journal of Cancer, Vol. 139, 2016, Nr. 6, pp. 1350 – 1357
-
In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid AdministrationIn: The Journal of Immunology (JI), Vol. 196, 2016, Nr. 6, pp. 2860 – 2869
-
The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated NeutrophilsIn: Frontiers in Immunology, Vol. 7, 2016, pp. 629DOI (Open Access)
-
Type i IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and humanIn: International Journal of Cancer, Vol. 138, 2016, Nr. 8, pp. 1982 – 1993DOI (Open Access)
-
The Mechanism of Type I Interferon-Mediated Polarization of Tumor-Associated Neutrophils in Mice and HumanIn: Blood, Vol. 126, 2015, Nr. 23
